A detailed history of Bank Of America Corp transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 298,685 shares of KPTI stock, worth $262,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
298,685
Previous 157,915 89.14%
Holding current value
$262,842
Previous $238,000 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $122,469 - $222,416
140,770 Added 89.14%
298,685 $259,000
Q1 2024

May 15, 2024

SELL
$0.72 - $1.66 $106,948 - $246,576
-148,540 Reduced 48.47%
157,915 $238,000
Q4 2023

Feb 14, 2024

SELL
$0.68 - $1.31 $20,389 - $39,279
-29,984 Reduced 8.91%
306,455 $263,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $4.59 $3.26 Million - $8.36 Million
-1,821,342 Reduced 84.41%
336,439 $602,000
Q1 2023

May 12, 2023

BUY
$2.84 - $3.92 $1.84 Million - $2.53 Million
646,615 Added 42.79%
2,157,781 $8.39 Million
Q4 2022

Feb 10, 2023

BUY
$2.48 - $5.93 $1.93 Million - $4.62 Million
779,302 Added 106.48%
1,511,166 $5.14 Million
Q3 2022

Nov 14, 2022

BUY
$4.08 - $5.82 $1.03 Million - $1.47 Million
252,446 Added 52.66%
731,864 $4 Million
Q2 2022

Aug 12, 2022

SELL
$4.15 - $8.37 $2.64 Million - $5.33 Million
-636,812 Reduced 57.05%
479,418 $2.16 Million
Q1 2022

May 16, 2022

BUY
$5.91 - $14.38 $5.09 Million - $12.4 Million
861,362 Added 337.96%
1,116,230 $8.23 Million
Q4 2021

Feb 08, 2022

BUY
$5.21 - $8.61 $98,745 - $163,185
18,953 Added 8.03%
254,868 $1.64 Million
Q3 2021

Nov 15, 2021

BUY
$4.45 - $10.63 $2,167 - $5,176
487 Added 0.21%
235,915 $1.37 Million
Q2 2021

Sep 13, 2021

BUY
$8.11 - $11.11 $1.91 Million - $2.62 Million
235,428 New
235,428 $2.43 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $70.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.